Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons

Marcello Maggio, Fulvio Lauretani, Francesca de Vita, Shehzad Basaria, Giuseppe Lippi, Valeria Buttò, Michele Luci, Chiara Cattabiani, Graziano Ceresini, Ignazio Verzicco, Luigi Ferrucci, Gian Paolo Ceda

Research output: Contribution to journalArticle

Abstract

Mobility-disability is a common condition in older individuals. Many factors, including the age-related hormonal dysregulation, may concur to the development of disability in the elderly. In fact, during the aging process it is observed an imbalance between anabolic hormones that decrease (testosterone, dehydroepiandrosterone sulphate (DHEAS), estradiol, insulin like growth factor-1 (IGF-1) and Vitamin D) and catabolic hormones (cortisol, thyroid hormones) that increase. We start this review focusing on the mechanisms by which anabolic and catabolic hormones may affect physical performance and mobility. To address the role of the hormonal dysregulation to mobility-disability, we start to discuss the contribution of the single hormonal derangement. The studies used in this review were selected according to the period of time of publication, ranging from 2002 to 2013, and the age of the participants (≥65 years). We devoted particular attention to the effects of anabolic hormones (DHEAS, testosterone, estradiol, Vitamin D and IGF-1) on both skeletal muscle mass and strength, as well as other objective indicators of physical performance. We also analyzed the reasons beyond the inconclusive data coming from RCTs using sex hormones, thyroid hormones, and vitamin D (dosage, duration of treatment, baseline hormonal values and reached hormonal levels). We finally hypothesized that the parallel decline of anabolic hormones has a higher impact than a single hormonal derangement on adverse mobility outcomes in older population. Given the multifactorial origin of low mobility, we underlined the need of future synergistic optional treatments (micronutrients and exercise) to improve the effectiveness of hormonal treatment and to safely ameliorate the anabolic hormonal status and mobility in older individuals.

Original languageEnglish (US)
Pages (from-to)3119-3148
Number of pages30
JournalCurrent Pharmaceutical Design
Volume20
Issue number19
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Hormones
Vitamin D
Dehydroepiandrosterone Sulfate
Somatomedins
Thyroid Hormones
Testosterone
Estradiol
Micronutrients
Age Factors
Gonadal Steroid Hormones
Muscle Strength
Hydrocortisone
Publications
Skeletal Muscle
Exercise
Therapeutics
Population

Keywords

  • Mobility
  • Multiple hormonal derangement
  • Muscle function
  • Older persons

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Medicine(all)

Cite this

Maggio, M., Lauretani, F., de Vita, F., Basaria, S., Lippi, G., Buttò, V., ... Ceda, G. P. (2014). Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Current Pharmaceutical Design, 20(19), 3119-3148. https://doi.org/10.2174/13816128113196660062

Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. / Maggio, Marcello; Lauretani, Fulvio; de Vita, Francesca; Basaria, Shehzad; Lippi, Giuseppe; Buttò, Valeria; Luci, Michele; Cattabiani, Chiara; Ceresini, Graziano; Verzicco, Ignazio; Ferrucci, Luigi; Ceda, Gian Paolo.

In: Current Pharmaceutical Design, Vol. 20, No. 19, 2014, p. 3119-3148.

Research output: Contribution to journalArticle

Maggio, M, Lauretani, F, de Vita, F, Basaria, S, Lippi, G, Buttò, V, Luci, M, Cattabiani, C, Ceresini, G, Verzicco, I, Ferrucci, L & Ceda, GP 2014, 'Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons', Current Pharmaceutical Design, vol. 20, no. 19, pp. 3119-3148. https://doi.org/10.2174/13816128113196660062
Maggio, Marcello ; Lauretani, Fulvio ; de Vita, Francesca ; Basaria, Shehzad ; Lippi, Giuseppe ; Buttò, Valeria ; Luci, Michele ; Cattabiani, Chiara ; Ceresini, Graziano ; Verzicco, Ignazio ; Ferrucci, Luigi ; Ceda, Gian Paolo. / Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. In: Current Pharmaceutical Design. 2014 ; Vol. 20, No. 19. pp. 3119-3148.
@article{07ba2f4ffef34937bf42874cbe88b9fd,
title = "Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons",
abstract = "Mobility-disability is a common condition in older individuals. Many factors, including the age-related hormonal dysregulation, may concur to the development of disability in the elderly. In fact, during the aging process it is observed an imbalance between anabolic hormones that decrease (testosterone, dehydroepiandrosterone sulphate (DHEAS), estradiol, insulin like growth factor-1 (IGF-1) and Vitamin D) and catabolic hormones (cortisol, thyroid hormones) that increase. We start this review focusing on the mechanisms by which anabolic and catabolic hormones may affect physical performance and mobility. To address the role of the hormonal dysregulation to mobility-disability, we start to discuss the contribution of the single hormonal derangement. The studies used in this review were selected according to the period of time of publication, ranging from 2002 to 2013, and the age of the participants (≥65 years). We devoted particular attention to the effects of anabolic hormones (DHEAS, testosterone, estradiol, Vitamin D and IGF-1) on both skeletal muscle mass and strength, as well as other objective indicators of physical performance. We also analyzed the reasons beyond the inconclusive data coming from RCTs using sex hormones, thyroid hormones, and vitamin D (dosage, duration of treatment, baseline hormonal values and reached hormonal levels). We finally hypothesized that the parallel decline of anabolic hormones has a higher impact than a single hormonal derangement on adverse mobility outcomes in older population. Given the multifactorial origin of low mobility, we underlined the need of future synergistic optional treatments (micronutrients and exercise) to improve the effectiveness of hormonal treatment and to safely ameliorate the anabolic hormonal status and mobility in older individuals.",
keywords = "Mobility, Multiple hormonal derangement, Muscle function, Older persons",
author = "Marcello Maggio and Fulvio Lauretani and {de Vita}, Francesca and Shehzad Basaria and Giuseppe Lippi and Valeria Butt{\`o} and Michele Luci and Chiara Cattabiani and Graziano Ceresini and Ignazio Verzicco and Luigi Ferrucci and Ceda, {Gian Paolo}",
year = "2014",
doi = "10.2174/13816128113196660062",
language = "English (US)",
volume = "20",
pages = "3119--3148",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "19",

}

TY - JOUR

T1 - Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons

AU - Maggio, Marcello

AU - Lauretani, Fulvio

AU - de Vita, Francesca

AU - Basaria, Shehzad

AU - Lippi, Giuseppe

AU - Buttò, Valeria

AU - Luci, Michele

AU - Cattabiani, Chiara

AU - Ceresini, Graziano

AU - Verzicco, Ignazio

AU - Ferrucci, Luigi

AU - Ceda, Gian Paolo

PY - 2014

Y1 - 2014

N2 - Mobility-disability is a common condition in older individuals. Many factors, including the age-related hormonal dysregulation, may concur to the development of disability in the elderly. In fact, during the aging process it is observed an imbalance between anabolic hormones that decrease (testosterone, dehydroepiandrosterone sulphate (DHEAS), estradiol, insulin like growth factor-1 (IGF-1) and Vitamin D) and catabolic hormones (cortisol, thyroid hormones) that increase. We start this review focusing on the mechanisms by which anabolic and catabolic hormones may affect physical performance and mobility. To address the role of the hormonal dysregulation to mobility-disability, we start to discuss the contribution of the single hormonal derangement. The studies used in this review were selected according to the period of time of publication, ranging from 2002 to 2013, and the age of the participants (≥65 years). We devoted particular attention to the effects of anabolic hormones (DHEAS, testosterone, estradiol, Vitamin D and IGF-1) on both skeletal muscle mass and strength, as well as other objective indicators of physical performance. We also analyzed the reasons beyond the inconclusive data coming from RCTs using sex hormones, thyroid hormones, and vitamin D (dosage, duration of treatment, baseline hormonal values and reached hormonal levels). We finally hypothesized that the parallel decline of anabolic hormones has a higher impact than a single hormonal derangement on adverse mobility outcomes in older population. Given the multifactorial origin of low mobility, we underlined the need of future synergistic optional treatments (micronutrients and exercise) to improve the effectiveness of hormonal treatment and to safely ameliorate the anabolic hormonal status and mobility in older individuals.

AB - Mobility-disability is a common condition in older individuals. Many factors, including the age-related hormonal dysregulation, may concur to the development of disability in the elderly. In fact, during the aging process it is observed an imbalance between anabolic hormones that decrease (testosterone, dehydroepiandrosterone sulphate (DHEAS), estradiol, insulin like growth factor-1 (IGF-1) and Vitamin D) and catabolic hormones (cortisol, thyroid hormones) that increase. We start this review focusing on the mechanisms by which anabolic and catabolic hormones may affect physical performance and mobility. To address the role of the hormonal dysregulation to mobility-disability, we start to discuss the contribution of the single hormonal derangement. The studies used in this review were selected according to the period of time of publication, ranging from 2002 to 2013, and the age of the participants (≥65 years). We devoted particular attention to the effects of anabolic hormones (DHEAS, testosterone, estradiol, Vitamin D and IGF-1) on both skeletal muscle mass and strength, as well as other objective indicators of physical performance. We also analyzed the reasons beyond the inconclusive data coming from RCTs using sex hormones, thyroid hormones, and vitamin D (dosage, duration of treatment, baseline hormonal values and reached hormonal levels). We finally hypothesized that the parallel decline of anabolic hormones has a higher impact than a single hormonal derangement on adverse mobility outcomes in older population. Given the multifactorial origin of low mobility, we underlined the need of future synergistic optional treatments (micronutrients and exercise) to improve the effectiveness of hormonal treatment and to safely ameliorate the anabolic hormonal status and mobility in older individuals.

KW - Mobility

KW - Multiple hormonal derangement

KW - Muscle function

KW - Older persons

UR - http://www.scopus.com/inward/record.url?scp=84897840813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897840813&partnerID=8YFLogxK

U2 - 10.2174/13816128113196660062

DO - 10.2174/13816128113196660062

M3 - Article

C2 - 24050169

AN - SCOPUS:84897840813

VL - 20

SP - 3119

EP - 3148

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 19

ER -